Department of Otolaryngology-Head and Neck Surgery, Kyung Hee University School of Medicine, Kyung Hee University Medical Center, Seoul, Republic of Korea.
Central Laboratory, Medical Science Research Institute, Kyung Hee University Medical Center, Seoul, Republic of Korea.
Anticancer Agents Med Chem. 2024;24(1):50-57. doi: 10.2174/0118715206267182231024105837.
Numerous studies have proven the efficacy and safety of natural products, and are widely used as attractive cancer treatments. The investigation of effective natural products for improving cancer treatment is a promising strategy. Combination treatment with radiosensitizers and radiotherapy (RT) is considered necessary for therapeutic improvement in head and neck squamous cell carcinoma(HNSCC).
This study aims to investigate whether Ephedra sinica (ES) extract could induce selective cell death in cancer cells and serve as a radiosensitizer for HNSCC.
HNSCC cells were pretreated with ES extract before radiation, and the radiosensitizing activity was assessed using a colony formation assay. Radiation-induced cell death was evaluated using an annexinV-FITC assay. Western blotting was performed to confirm cell death-related gene expression, including apoptosis and necrosis markers.
ES extract significantly inhibited HNSCC cell viability (FaDu and SNU1076), while having minimal effect on normal HaCaT cells. When HNSCC cells were irradiated with 2, 4, or 8 Gy and cultured with ES extract (25 μg/mL), they exhibited increased radiation sensitivity compared to non-treated cells. The combination of ES extract and radiation resulted in increased cell death compared to non-treated, ES-treated, or irradiated cells. The apoptosis marker BAX and necrosis marker p-MLKL expression levels were also elevated following the combination treatment.
ES extract demonstrated significant cytotoxic potential in HNSCC cells without affecting normal cells. It enhanced the radiosensitivity of HNSCC cells by upregulating BAX and p-MLKL expression, leading to increased cell death. These results suggest ES extract exhibits a potential radiosensitizing capacity in HNSCC.
大量研究已证实天然产物的疗效和安全性,并被广泛用作有吸引力的癌症治疗方法。研究有效的天然产物以改善癌症治疗是一种有前途的策略。联合使用放射增敏剂和放射治疗(RT)被认为是改善头颈部鳞状细胞癌(HNSCC)治疗的必要手段。
本研究旨在探讨麻黄提取物是否能诱导癌细胞选择性死亡,并作为 HNSCC 的放射增敏剂。
HNSCC 细胞在接受辐射前用 ES 提取物预处理,通过集落形成实验评估放射增敏活性。通过 AnnexinV-FITC 检测评估辐射诱导的细胞死亡。通过 Western blot 验证与细胞死亡相关的基因表达,包括凋亡和坏死标志物。
ES 提取物显著抑制 HNSCC 细胞活力(FaDu 和 SNU1076),而对正常 HaCaT 细胞的影响最小。当 HNSCC 细胞接受 2、4 或 8Gy 辐射并与 ES 提取物(25μg/ml)培养时,与未经处理的细胞相比,表现出更高的辐射敏感性。与未经处理、ES 处理或辐射的细胞相比,ES 提取物和辐射的组合导致细胞死亡增加。组合处理后,凋亡标志物 BAX 和坏死标志物 p-MLKL 的表达水平也升高。
ES 提取物在不影响正常细胞的情况下,对 HNSCC 细胞表现出显著的细胞毒性潜力。它通过上调 BAX 和 p-MLKL 的表达增强了 HNSCC 细胞的放射敏感性,导致细胞死亡增加。这些结果表明 ES 提取物在 HNSCC 中具有潜在的放射增敏能力。